Kala Pharmaceuticals Inc (KALA)

19.650
+0.680(+3.58%)
After Hours
19.500
-0.150(-0.763%)
- Real-time Data
  • Volume:
    953,733
  • Day's Range:
    18.000 - 20.917
  • 52 wk Range:
    3.544 - 97.000

KALA Overview

Prev. Close
18.97
Day's Range
18-20.917
Revenue
3.89M
Open
18.3
52 wk Range
3.544-97
EPS
-54.64
Volume
953,733
Market Cap
31.35M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
2,438,329
P/E Ratio
-0.36
Beta
0.877
1-Year Change
-49.03%
Shares Outstanding
1,595,237
Next Earnings Date
Mar 28, 2023
What is your sentiment on Kala Pharma?
or
Market is currently closed. Voting is open during market hours.

Kala Pharmaceuticals Inc News

Kala Pharmaceuticals Inc Analysis

Kala Pharmaceuticals Inc Company Profile

Kala Pharmaceuticals Inc Company Profile

Employees
192

Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company’s product candidates include KPI-012, which is in clinical development stage for the treatment of persistent corneal epithelial defects; EYSUVIS for the short-term treatment of the signs and symptoms of dry eye disease; and INVELTYS, a topical twice-a-day ocular steroid for the treatment of post-operative inflammation and pain following ocular surgery. Its preclinical development products comprise KPI-287 that inhibits the vascular endothelial and platelet derived growth factors for the treatment of retinal diseases, including wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion; and selective glucocorticoid receptor modulators program, a novel class of compounds to regulate gene expression through the transrepression pathway while avoiding the transactivation pathway. The company was formerly known as Hanes Newco, Inc. and changed its name to Kala Pharmaceuticals, Inc. in December 2009. Kala Pharmaceuticals, Inc. was incorporated in 2009 and is headquartered in Watertown, Massachusetts.

Read More

Analyst Price Target

Average45.875 (+133.461% Upside)
High87.500
Low12.000
Price19.650
No. of Analysts4
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyStrong BuyStrong BuyBuySell
Technical IndicatorsBuyStrong BuyStrong BuyStrong SellStrong Sell
SummaryBuyStrong BuyStrong BuyNeutralStrong Sell
  • sold, protect profits $$
    0
    • how did you know about Kala ? I follow few stocks but this one never came to my attention...🫣
      0
    • from tuesday mornings pre market it was here on the pre market top gainers . It was a top gainer all week. Just Keep a eye on that list .
      0
  • Buy and hold is awesome. KALA
    0
    • Test Can Not SHORT 👉 Never Buy 👉 DELETE
      1
      • Will we rise back to 1??
        0
        • buy and hold
          0
          • how long u holding where do you think its gonna go?
            0
          • if it still above 0.92 it's a good sign to going to 1.8
            0
          • if not it do that l think it's gonna go
            0
        • thinking about buy
          0
          • to 0.66
            0
            • target 5.9?
              1
              • Afther the new year it will jump
                0
                • What are the thoughts of the Lord? where is the bottom. Will it be 14 again and when
                  0